EnVVeno Historical Income Statement
| NVNO Stock | USD 4.96 0.05 1.00% |
Historical analysis of EnVVeno Medical income statement accounts such as Total Operating Expenses of 12.5 M can show how well enVVeno Medical Corp performed in making a profits. Evaluating EnVVeno Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of EnVVeno Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining enVVeno Medical Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether enVVeno Medical Corp is a good buy for the upcoming year.
EnVVeno |
About EnVVeno Income Statement Analysis
enVVeno Medical Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to EnVVeno Medical shareholders. The income statement also shows EnVVeno investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
EnVVeno Medical Income Statement Chart
enVVeno Medical Corp Income Statement is one of the three primary financial statements used for reporting EnVVeno's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of enVVeno Medical Corp revenue and expense. EnVVeno Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, EnVVeno Medical's Total Other Income Expense Net is very stable compared to the past year. As of the 29th of May 2024, Net Interest Income is likely to grow to about 180.6 K, while Depreciation And Amortization is likely to drop about 350.3 K. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of enVVeno Medical Corp. It is also known as EnVVeno Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from EnVVeno Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into enVVeno Medical Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. At this time, EnVVeno Medical's Total Other Income Expense Net is very stable compared to the past year. As of the 29th of May 2024, Net Interest Income is likely to grow to about 180.6 K, while Depreciation And Amortization is likely to drop about 350.3 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 18.7K | 263K | 236.7K | 224.9K | Depreciation And Amortization | 140.2K | 423K | 546K | 350.3K |
EnVVeno Medical income statement Correlations
Click cells to compare fundamentals
EnVVeno Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EnVVeno Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 1.0M | 172.2K | 140.2K | 423K | 546K | 350.3K | |
| Interest Expense | 49.9K | 3.7K | 18.7K | 263K | 236.7K | 224.9K | |
| Other Operating Expenses | 7.1M | 9.1M | 16.9M | 24.9M | 25.2M | 12.7M | |
| Operating Income | (7.7M) | (9.1M) | (16.9M) | (24.9M) | (25.2M) | (24.0M) | |
| Ebit | (7.7M) | (9.1M) | (16.9M) | (24.9M) | (25.2M) | (24.0M) | |
| Ebitda | (6.6M) | (9.0M) | (16.8M) | (24.5M) | (24.7M) | (23.5M) | |
| Total Operating Expenses | 7.1M | 9.1M | 16.9M | 24.9M | 24.7M | 12.5M | |
| Income Before Tax | (7.6M) | (9.1M) | (16.5M) | (24.7M) | (23.5M) | (22.3M) | |
| Total Other Income Expense Net | 49.9K | (360.0) | 364.7K | 263K | 1.7M | 1.8M | |
| Net Income | (7.6M) | (8.9M) | (16.2M) | (24.3M) | (23.5M) | (22.3M) | |
| Income Tax Expense | 588.8K | (215.5K) | (331.4K) | (365K) | (419.8K) | (398.8K) | |
| Gross Profit | 31.2K | (384.0K) | (452.9K) | (525K) | (546K) | (518.7K) | |
| Net Interest Income | 49.9K | 3.7K | 18.7K | 161K | 172K | 180.6K | |
| Selling General Administrative | 4.9M | 4.9M | 11.2M | 15.0M | 12.0M | 9.4M | |
| Net Income From Continuing Ops | (7.6M) | (9.1M) | (16.5M) | (24.7M) | (24.0M) | (22.8M) | |
| Research Development | 2.2M | 4.3M | 5.7M | 9.9M | 13.6M | 14.3M | |
| Reconciled Depreciation | 396.7K | 384.0K | 452.9K | 525K | 542K | 404.4K | |
| Net Income Applicable To Common Shares | (7.6M) | (9.7M) | (16.5M) | (24.7M) | (22.2M) | (21.1M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for EnVVeno Stock analysis
When running EnVVeno Medical's price analysis, check to measure EnVVeno Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnVVeno Medical is operating at the current time. Most of EnVVeno Medical's value examination focuses on studying past and present price action to predict the probability of EnVVeno Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnVVeno Medical's price. Additionally, you may evaluate how the addition of EnVVeno Medical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is EnVVeno Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.63) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.